The NCCN Oncology Research Program (ORP) has developed a comprehensive program of scientific advisors and research platforms to foster the development of world-class therapies to treat people with cancer. The program has been successful in bringing together leading academic scientists, clinicians, and pharmacists to work with pharmaceutical and biotechnology companies dedicated to developing effective new treatments for cancer. The NCCN ORP’s core services focus on assisting companies with drug development plans and strategies, facilitating the conduct of preclinical, translational, and clinical research at NCCN Member Institutions, ensuring that results of funded research projects are publicly disseminated, and working with the research community to develop oncology research best practices.
The NCCN ORP strives to improve the quality of life for patients and reduce cancer-related deaths by advancing cancer therapies through research. We believe we can achieve this goal by supporting oncology preclinical, translational, and clinical research at the NCCN Member Institutions. We recognize the importance of developing and maintaining strong alliances with industry and actively facilitating collaborations between academia and industry drug developers making important scientific strides in the field of oncology. It is NCCN's vision to have the NCCN ORP become a Center for Excellence in the United States for providing outstanding research and research services.
Contact the NCCN Oncology Research Program